Cyclo Therapeutics Inc

CYTH:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/22/21 EST
6.22quote price arrow up+0.07 (+1.14%)
Volume
2,016
Close
6.15quote price arrow up+0.01 (+0.16%)
Volume
201,535
52 week range
3.40 - 30.00

...

Loading . . .

KEY STATS

  • Open6.05
  • Day High6.32
  • Day Low6.02
  • Prev Close6.14
  • 52 Week High30.00
  • 52 Week High Date03/30/20
  • 52 Week Low3.40
  • 52 Week Low Date11/19/20
  • Market Cap28.11M
  • Shares Out4.57M
  • 10 Day Average Volume0.34M
  • Dividend-
  • Dividend Yield-
  • Beta-1.03
  • 1 Year % Change-67.63

RATIOS/PROFITABILITY

  • EPS (TTM)-6.92
  • P/E (TTM)-0.89
  • Fwd P/E (NTM)-3.14
  • EBITDA (MRQ)-8.75M
  • ROE (MRQ)-601.41%
  • Revenue (MRQ)0.99M
  • Gross Margin (MRQ)92.67%
  • Net Margin (MRQ)-903.12%
  • Debt To Equity (MRQ)-30.22%

EVENTS

  • Earnings Date03/31/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Cyclo Therapeutics Inc News

There is no recent news for this security.

Latest CYTH News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Cyclo Therapeutics, Inc. is a clinical stage biotechnology company. The Company develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease. The Company’s Trappsol Cyclo, an orphan drug designated product in the United States and Europe, is the subject of three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. NPC is a fatal cholesterol metabolism disease that impacts the...
Address
6714 NW 16th Street, Suite B
Gainesville, FL
32653
United States